AngioDynamics

370 articles about AngioDynamics

• AngioDynamics to Present at the Needham 22nd Annual Virtual Healthcare Conference

  4/11/2023

  AngioDynamics, Inc. announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the Needham 22nd Annual Virtual Healthcare Conference at 8:00 a.m. ET on Monday, April 17, 2023.

• AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance

  3/30/2023

  AngioDynamics, Inc. (NASDAQ: ANGO) today announced financial results for the third quarter of fiscal year 2023, which ended February 28, 2023.

• AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023

  3/13/2023

  AngioDynamics, Inc. (NASDAQ: ANGO) today announced that it will report financial results for the third quarter of fiscal year 2023 before the market open on Thursday, March 30, 2023.

• AngioDynamics to Participate in Three Investor Conferences in March

  2/28/2023

  AngioDynamics, Inc. today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in the following three investor conferences in March.

• AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results; Reaffirms Guidance

  1/5/2023

  AngioDynamics, Inc. today announced financial results for the second quarter of fiscal year 2023, which ended November 30, 2022.

• AngioDynamics to Present at the J.P. Morgan Healthcare Conference-Dec 20, 2022

  12/20/2022

  AngioDynamics, Inc. (NASDAQ: ANGO) today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan 41st Annual Healthcare Conference at 8:15 a.m. PT (11:15 a.m. ET) on Thursday, January 12, 2023 in San Francisco, CA.

• AngioDynamics to Report Fiscal 2023 Second Quarter Financial Results on January 5, 2023

  12/15/2022

  AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will report financial results for the second quarter of fiscal year 2023 before the market open on Thursday, January 5, 2023.

• AngioDynamics to Present at the Piper Sandler Healthcare Conference

  11/17/2022

  AngioDynamics, Inc. announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the Piper Sandler 34th Annual Healthcare Conference at 10:10 a.m. ET on Wednesday, November 30, 2022.

• AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F1885 PE System in Treatment of Pulmonary Embolism

  10/31/2022

  AngioDynamics, Inc. (NASDAQ: ANGO) today announced the enrollment of the first patient in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV).

• AngioDynamics Reports Fiscal 2023 First Quarter Financial Results; Reaffirms Guidance

  10/6/2022

  AngioDynamics, Inc. today announced financial results for the first quarter of fiscal year 2023, which ended August 31, 2022.

• AngioDynamics Reports Fiscal Year 2022 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2023 Guidance

  7/12/2022

  AngioDynamics, Inc. today announced financial results for the fourth quarter and fiscal year 2022, which ended May 31, 2022.

• AngioDynamics to Report Fiscal 2022 Fourth Quarter and Full-Year Financial Results on July 12, 2022

  6/15/2022

  AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that it will report financial results for the fourth quarter and fiscal year 2022 before the market open on Tuesday, July 12, 2022.

• AngioDynamics to Present at the UBS Global Healthcare Conference - May 16, 2022

  5/16/2022

  AngioDynamics, Inc. announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the UBS Global Healthcare Conference at 4:15 p.m. ET on Monday, May 23, 2022.

• AngioDynamics to Present at the BofA Securities Healthcare Conference

  5/3/2022

  AngioDynamics, Inc. announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the BofA Securities Healthcare Conference at 10:00 a.m. PT on Tuesday, May 10, 2022.

• 

  Clinical Catch-Up: AACR, AAN and COVID-19

  4/18/2022

  It was a very busy week for clinical trial news, with much of it coming out of the American Association of Cancer Research Annual Meeting. Read on for details.

• AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance

  4/7/2022

  AngioDynamics, Inc. today announced financial results for the third quarter of fiscal year 2022, which ended February 28, 2022.

• AngioDynamics to Present at the Needham Virtual Healthcare Conference - Apr 04, 2022

  4/4/2022

  AngioDynamics, Inc., a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system and improving quality of life for patients, announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 21st Annual Needham Virtual Healthcare Conference at 2:15 p.m. ET on Monday, April 11, 2022.

• AngioDynamics to Report Fiscal 2022 Third Quarter Financial Results on April 7, 2022

  3/14/2022

  AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the third quarter of fiscal year 2022 before the market open on Thursday, April 7, 2022.

• AngioDynamics to Present at Three Investor Conferences in March 2022

  3/8/2022

  AngioDynamics, Inc. announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the following three investor conferences in March.

• AngioDynamics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

  2/8/2022

  AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.